Literature DB >> 11389519

Prophylaxis strategies for solid-organ transplantation.

R Soave1.   

Abstract

In addition to the net state of immunosuppression, the risk of infection after transplantation is largely determined by the transplant recipient's epidemiologic exposures. Potential sources of infection in the transplant recipient include the environment and the recipient's endogenous flora. This article presents aspects of prevention of infection after solid-organ transplantation such as avoidance of epidemiologic exposures, antibacterial prophylaxis, prophylaxis for tuberculin-positive transplant recipients, and prophylaxis against infections with Pneumocystis carinii and Toxoplasma gondii.

Entities:  

Mesh:

Year:  2001        PMID: 11389519     DOI: 10.1086/320901

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  10 in total

1.  Cardiac Transplantation: Pre-transplant Infectious Diseases Evaluation and Post-transplant Prophylaxis.

Authors:  Susan Keay
Journal:  Curr Infect Dis Rep       Date:  2002-08       Impact factor: 3.725

Review 2.  [Infections after organ transplantation].

Authors:  W V Kern; D Wagner; H H Hirsch
Journal:  Internist (Berl)       Date:  2005-06       Impact factor: 0.743

Review 3.  Microbiota—implications for immunity and transplantation.

Authors:  Jonathan S Bromberg; W Florian Fricke; C Colin Brinkman; Thomas Simon; Emmanuel F Mongodin
Journal:  Nat Rev Nephrol       Date:  2015-05-12       Impact factor: 28.314

Review 4.  Pentamidine in Pneumocystis jirovecii prophylaxis in heart transplant recipients.

Authors:  Adem Ilkay Diken; Ozlem Erçen Diken; Onur Hanedan; Seyhan Yılmaz; Ata Niyazi Ecevit; Emir Erol; Adnan Yalçınkaya
Journal:  World J Transplant       Date:  2016-03-24

5.  Correlation of parasite load determined by quantitative PCR to clinical outcome in a heart transplant patient with disseminated toxoplasmosis.

Authors:  Solène Patrat-Delon; Jean-Pierre Gangneux; Sylvain Lavoué; Bernard Lelong; Claude Guiguen; Yves le Tulzo; Florence Robert-Gangneux
Journal:  J Clin Microbiol       Date:  2010-05-12       Impact factor: 5.948

6.  Molecular diagnosis of toxoplasmosis in immunocompromised patients: a 3-year multicenter retrospective study.

Authors:  Florence Robert-Gangneux; Yvon Sterkers; Hélène Yera; Isabelle Accoceberry; Jean Menotti; Sophie Cassaing; Marie-Pierre Brenier-Pinchart; Christophe Hennequin; Laurence Delhaes; Julie Bonhomme; Isabelle Villena; Emeline Scherer; Frédéric Dalle; Feriel Touafek; Denis Filisetti; Emmanuelle Varlet-Marie; Hervé Pelloux; Patrick Bastien
Journal:  J Clin Microbiol       Date:  2015-03-11       Impact factor: 5.948

7.  Cerebral toxoplasmosis in a diffuse large B cell lymphoma patient.

Authors:  Lina Savsek; Tanja Ros Opaskar
Journal:  Radiol Oncol       Date:  2016-02-16       Impact factor: 2.991

8.  Worldwide clinical practices in perioperative antibiotic therapy for lung transplantation.

Authors:  Benjamin Coiffard; Eloi Prud'Homme; Sami Hraiech; Nadim Cassir; Jérôme Le Pavec; Romain Kessler; Federica Meloni; Marc Leone; Pascal Alexandre Thomas; Martine Reynaud-Gaubert; Laurent Papazian
Journal:  BMC Pulm Med       Date:  2020-04-29       Impact factor: 3.317

9.  Unusual presentation of primary toxoplasmosis infection in a kidney-transplant patient complicated by an acute left-ventricular failure.

Authors:  Benjamin Hébraud; Nassim Kamar; Jean-Sébastien Borde; Marie-Hélène Bessières; Michel Galinier; Lionel Rostaing
Journal:  NDT Plus       Date:  2008-10-18

10.  Detection of Toxoplasma gondii from Clinical Specimens of Patients Receiving Renal Transplant Using ELISA and PCR.

Authors:  Morteza Izadi; Nematollah Jonaidi Jafari; Abbas Mahmoodzadeh Poornaki; Javid Sadraei; Babak Rezavand; Hamid Reza Mirzaei; Hossein Zarrinfar; Abulfazl Khedive
Journal:  Nephrourol Mon       Date:  2013-11-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.